The Complete Change of Blood in High-Risk Patients in the Preliminary Stages of COVID-19
preprint
OA: gold
publisher-OA-unknown
Abstract
The difficulty of finding an effective and suitable vaccination to control COVID-19 globally makes necessary an alternative medical solution before it is so late. This research proposal suggests the complete change of the blood (full blood change and transfusion) in the preliminary stages of COVID-19 (after detected in severe cases) urgently. We can observe that the main problem of COVID-19 is high-risk groups such as high blood pressure, diabetic, old age, weak immunization systems, respectively. This research is interested in proposing the uses of complete change blood in the early stages of COVID-19. The COVID-19 shows many differences and behavior from other viruses around us: the COVID-19 attacks sensitive organs, especially the lungs and liver, in preliminary research results. Finally, we suggest to do it initial experiments to verify this scientific statement urgently.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T05:10:58.409756+00:00
License: publisher-OA-unknown
· commercial use NOT OK
· attribution required